Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancerAya Suzuki, Toshihiro Nukiwa, Shunichi Sugawara et al.|Cancer Treatment and Research Communications|2017Cited by 6